TLSA
Tiziana Life Sciences Ltd
NASDAQ · Healthcare · Biotechnology · GB
$1.02
+4.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2496.24x
- Price / sales
- —
- Price / cash flow
- -9.23x
Enterprise value
- Enterprise value
- $126.3M
- EV / sales
- —
- EV / EBITDA
- -2.99x
- EV / EBIT
- -2.91x
- Market cap
- $129.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025